secwatch.observer — SEC 8-K summary
======================================

Issuer:     BRAINSTORM CELL THERAPEUTICS INC. (BCLI)
CIK:        0001137883
Form:       8-K
Filed at:   2024-06-28T23:59:59+00:00
Accession:  0001104659-24-075995
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BrainStorm Cell Therapeutics raises $4.0M in registered direct offering and warrants
--------------------------------------------------------------------------------

- Gross proceeds ~$4.0M from sale of 11.1M shares or pre-funded warrants at $0.36/share.
- Private placement of warrants to buy 16.7M shares at $0.3912, exercisable after 6 months, 5-year term.
- Existing warrants for 4.05M shares amended: exercise price cut to $0.3912, expiry extended to 2029.
- Offering expected June 28, 2024; Maxim Group as placement agent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1137883/000110465924075995/0001104659-24-075995-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1137883/000110465924075995/tm2418388d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-075995

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer